Guoji Yanke Zazhi (Mar 2017)

Current progress on clinical application of cyclosporine A

  • Yan-Ning Yang,
  • Jia-Yue Zhu,
  • Xiu-Sheng Song,
  • Xia Li,
  • Tuo Li,
  • Jia-Zhang Li

DOI
https://doi.org/10.3980/j.issn.1672-5123.2017.3.18
Journal volume & issue
Vol. 17, no. 3
pp. 463 – 466

Abstract

Read online

Cyclosporine A is a new and potent immunosuppressant with high specificity and is widely used in controlling a variety of immunological rejection after organ transplantation. Research found that cyclosporine A suppresses the immune rejection in moderate to severe dry eye syndrome treatment. For mooren ulcers and autoimmune eye diseases, it has a significant effect. The application progress of Cyclosporine A in clinical ophthalmology is now reviewed.

Keywords